Ret Proto-Oncogene antibody (FITC)

Catalog No. ABIN2627589

The Rabbit Polyclonal anti-Ret Proto-Oncogene antibody has been validated for WB. It is suitable to detect Ret Proto-Oncogene in samples from Chemical.

Quick Overview for Ret Proto-Oncogene antibody (FITC) (ABIN2627589)

Target: Ret Proto-Oncogene (RET)

Reactivity: Chemical

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Ret Proto-Oncogene antibody is conjugated to FITC

Application: Western Blotting (WB)

Product Details anti-Ret Proto-Oncogene Antibody (FITC)

Specificity: RET

Purification: Affinity purified

Immunogen: Small Molecule, vitamin A conjugated to OVA.
ImmunogenType: Hapten

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: Lot specific

Buffer: PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid freeze-thaw cycles.

Storage: 4 °C

Storage Comment: Store at 4°C short term. Aliquot and store at -80°C long term.

Target Details for Ret Proto-Oncogene

Target: Ret Proto-Oncogene (RET)

Alternative Name: RET

Target Type: Chemical

Background: Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9

Gene ID: 5979

Pathways: RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation